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Background: This study investigated the relationships of thigh and waist circumference with the hemoglobin glycation index (HGI) 
and carotid atherosclerosis in patients with type 2 diabetes.
Methods: This observational study included 3,075 Korean patients with type 2 diabetes, in whom anthropometric measurements 
and carotid ultrasonography were conducted. HGI was defined as the measured hemoglobin A1c (HbA1c) level minus the predicted 
HbA1c level, which was calculated using the linear relationship between HbA1c and fasting plasma glucose levels. Carotid athero-
sclerosis was defined as a clearly isolated focal plaque or focal wall thickening >50% of the surrounding intima-media thickness.
Results: The frequency of a positive HGI decreased with increasing thigh circumference in men and increased with increasing waist 
circumference in women after adjusting for potential confounding variables. Thigh and waist circumference had a combined aug-
mentative effect on the likelihood of positive HGI, which was dramatically higher in patients in higher waist-to-thigh ratio quartiles 
(adjusted odds ratios for the highest compared to the lowest quartile: 1.595 in men and 1.570 in women). Additionally, the larger the 
thigh circumference, the lower the risk of carotid atherosclerosis, although in women, this relationship lacked significance after ad-
justment for potential confounders.
Conclusion: HGI was associated with thigh circumference in men and waist circumference in women. In addition, the combination 
of low thigh circumference and high waist circumference was strongly associated with a higher HGI in Korean patients with type 2 
diabetes. In particular, thigh circumference was associated with carotid atherosclerosis in men. However, further longitudinal studies 
are warranted.
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INTRODUCTION
According to data published by the Korean Diabetes Associa-
tion in 2018, one in seven (14.4%) Koreans over 30 years old 
had diabetes in 2016 [1]. Diabetes is a chronic disease that leads 
to retinopathy, nephropathy, cardiovascular disease, stroke, and 
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other serious complications. High blood glucose levels are the 
main factor in the development of these complications and are 
also associated with increased mortality [2,3]. 
Glycemic variability is the physiological consequence of both 
carbohydrate intake and the circadian rhythms of hormones in-
volved in the regulation of glucose metabolism [4]. Glycemic 
variability is known to be high in people with diabetes, espe-
cially in those with low body mass index (BMI) values [5].
To prevent diabetic complications, it is crucial to maintain 
proper blood glucose levels. To accomplish this goal, hemoglo-
bin A1c (HbA1c), fasting plasma glucose, and postprandial blood 
glucose levels should be maintained within target ranges [6].
Recently, the clinical significance of glucose variability has 
been highlighted in the context of the three aforementioned indi-
cators [7]. Even among patients with similar HbA1c levels, fluc-
tuations of blood glucose during the day can vary [8]. Similarly 
to fasting glucose, postprandial glucose, and HbA1c levels, diur-
nal variation in blood glucose levels is associated with the inci-
dence of complications, with a large magnitude of variation asso-
ciated with increased risk [9]. Therefore, it is important to reduce 
the diurnal variation of glucose in patients with diabetes [10,11].
Blood glucose can be measured using a continuous glucose 
monitoring system (CGMS) to evaluate diurnal glucose vari-
ability [12]. However, this system is not yet widely applied in 
clinical settings because the equipment is expensive and un-
comfortable to wear [13]. Furthermore, the values measured by 
CGMS and its target range have yet to be standardized, limiting 
the usage of CGMS [6].
The hemoglobin glycation index (HGI) is another indicator 
that can be easily used in clinical settings to assess fluctuations 
in blood glucose. As an indicator of blood glucose metabolism 
relevant to diabetic complications, the HGI reflects diurnal vari-
ation in glucose levels [14]. A previous study reported that a 
high HGI was associated with an increased risk of cardiovascu-
lar complications such as coronary artery disease, stroke, and 
peripheral arterial disease in patients with pre-diabetes or diabe-
tes [15]. The HGI has also been reported to be associated with 
an increased risk of coronary artery calcification in patients 
without diabetes, irrespective of HbA1c levels [16].
Thigh and waist circumference are physical measurements 
that are strongly associated with diabetes risk. As thigh circum-
ference increases, the risk of diabetes is reduced [17], and as it 
decreases, the risk of diabetes increases [18]. Thigh circumfer-
ence is also known to be independently associated with insulin 
resistance in patients with type 2 diabetes [19].
In contrast, increased waist circumference is associated with 
an increased risk of diabetes [17]. This relationship exists be-
cause waist circumference is an indicator of central obesity [20], 
which is strongly correlated with insulin resistance [21,22].
Although thigh and waist circumference are associated with 
the incidence of diabetes, and the HGI is known to be a major 
factor in the prediction of diabetic complications, little is known 
about the relationships of thigh and waist circumference with the 
HGI. The main purpose of this study was to investigate this rela-
tionship. Furthermore, we sought to understand the relationship 
between thigh circumference and the presence of carotid artery 
plaque, which is a cardiovascular complication of diabetes.
METHODS
Subjects
This cross-sectional survey study included 3,075 patients with 
diabetes (male, 1,569; female, 1,506) who were admitted to 
Huh’s Diabetes Center in Seoul between September 2002 and 
October 2016. The subjects of this study were patients with type 
2 diabetes who underwent carotid ultrasonography. To exclude 
the possibility of type 1 diabetes, we included only patients over 
30 years old with negative anti-glutamic acid decarboxylase anti-
body tests and with C-peptide levels higher than 0.6 ng/mL. Fur-
thermore, we included only patients for whom all variables re-
quired for the analysis had been evaluated. The study protocol 
was approved by the Institutional Review Board/Ethics Commit-
tee (IBR No.: 2019-I077) of Hallym University Sacred Heart 
Hospital. Informed written consent was obtained from all partici-
pants.
Measurements
All anthropometric values were measured with patients barefoot 
and wearing only light clothes [23]. BMI (kg/m2) was calculated 
using measured height and weight. Using a tape measure, waist 
circumference was measured after exhalation at the level mid-
way between the lowest rib margin and the iliac crest. Thigh 
circumference was measured directly below the gluteal fold at 
the left leg, and calf circumference was measured at the thickest 
part of the calf.
At their first visit, all patients underwent measurements of 
systolic blood pressure, diastolic blood pressure, and levels of 
fasting blood glucose (FPG), HbA1c, C-peptide, blood insulin, 
total cholesterol, low-density lipoprotein cholesterol, high-den-
sity lipoprotein cholesterol, and triglycerides. We evaluated the 
extent of insulin resistance and β-cell dysfunction using homeo-
static model assessment for insulin resistance (HOMA-IR) and 
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β-cell dysfunction (HOMA-B) calculated from fasting glucose 
and insulin levels using the formulas HOMA-IR=[glucose (mg/
dL)×insulin (µU/mL)]/405 and HOMA-B=[20×insulin (µU/
mL)]/[glucose (mg/dL)/18−3.5].
Participants’ age, sex, hypertension status, duration of diabe-
tes, lifestyle factors (drinking, smoking, and exercise status), 
and medication usage (hypoglycemic agents, antihypertensive 
agents, or statins) were examined using questionnaires. Carotid 
ultrasonography was conducted with a 10-MHz high-resolution 
carotid ultrasound device with a linear probe (LOGIQ 7, GE 
Healthcare, Milwaukee, WI, USA). The carotid arteries on both 
sides were observed, and a carotid plaque was defined as a dis-
tinctly hyperechoic lesion or a localized protrusion of the vessel 
wall with a thickness exceeding the intima-media thickness of 
the adjacent portion of the vessel wall by >50% [24].
Calculation of the HGI
The HGI can be expressed as the difference between the mea-
sured HbA1c and the predicted HbA1c [25]. To calculate the 
predicted HbA1c, a formula described in a previous study (pre-
dicted HbA1c=0.030×FPG+2.978) was used [15]. The greater 
the HGI, the greater the difference between the predicted 
HbA1c and the measured HbA1c. When the HGI value was 
zero or greater, we defined it as a positive HGI.
Statistical analyses
All continuous variables were expressed as mean±standard de-
viation, and nominal variables were expressed as percentages. 
First, subjects were grouped by sex. Then, each group was clas-
sified into four quartiles (Q1 through Q4) by both thigh circum-
ference and waist circumference. To minimize the effect of 
measurement errors, each group was partitioned at appropriate 
intervals. For each group, the odds ratios (ORs) for a positive 
HGI and the existence of carotid plaque were computed via lo-
gistic regression. The group with the smallest measurement val-
ues (Q1) was used as a reference for both comparisons. We con-
structed four models in total: one unadjusted model and three 
adjusted multiple logistic regression models. Each adjusted 
model had different adjustment schemes. The first model was 
adjusted for age and duration of diabetes, while the second was 
additionally adjusted for BMI. In addition to age, diabetes dura-
tion, and BMI, the third model was adjusted for systolic blood 
pressure, exercise status, smoking status, use of hypoglycemic 
agents (insulin, sulfonylureas, biguanides, alpha-glucosidase in-
hibitors, glitazones, dipeptidyl peptidase-4 inhibitors, or sodi-
um-glucose cotransporter 2 inhibitors), high-density lipoprotein 
Table 1. Baseline Clinical Characteristics of Participants 
Characteristic Total Men Women
Number 3,075 1,569 1,506
Age, yr 58.6±10.2 56.7±10.8 60.7±9.1
DM duration, yr 8.3±7.9 8.2±7.9 8.5±7.8
SBP, mm Hg 131.8±17.0 130.9±16.2 132.7±17.7
Hypertension (yes), % 38.2 34.0 42.7
Use of antihyperglycemic agents, %
   Insulin 10.6 8.9 12.4
   Sulfonylurea 49.6 48.3 50.9
   Biguanide 54.6 51.2 58.1
   α-Glucosidase inhibitor 9.7 9.6 9.9
   Glitazone 7.8 8.1 7.5
   DPP4 inhibitor 12.6 12.1 13.1
   SGLT2 inhibitor 0.2 0.3 0.1
Statin usage, % 23.9 19.1 29
Exercise (yes), % 67.3 68.6 65.9
Smoker (current), % 14.5 26.4 2.0
Smoker (ex), % 25.1 47.4 1.9
BMI, kg/m2 24.3±2.9 24.6±2.7 24.1±3.1
Waist circumference, cm 84.1±8.2 87.1±7.3 81.0±7.8
Hip circumference, cm 92.6±5.2 93.8±4.9 91.4±5.3
Thigh circumference, cm 44.5±3.6 45.2±3.5 43.8±3.5
Leg circumference, cm 34.7±2.9 36.0±2.7 33.3±2.4
Fasting plasma glucose, mg/dL 156.6±50.7 160.6±52.2 151.7±48.8
HbA1c, % 7.9±1.7 7.9±1.8 7.8±1.7
Hemoglobin glycation index 0.22±1.25 -0.06±1.24 0.07±1.18
C-peptide, ng/mL 2.05±0.94 2.07±0.89 2.03±0.99
Total cholesterol, mg/dL 187.9±41.0 185.6±41.0 190.4±40.8
Triglyceride, mg/dL 135.9±80.5 140.9±84.6 130.7±75.7
HDL-C, mg/dL 49.3±12.1 46.9±10.9 51.8±12.7
LDL-C, mg/dL 111.3±35.9 110.3±35.9 112.3±36.0
HOMA-IR 2.9±1.9 2.8±1.8 3.0±2.1
HOMA-B 37.7±28.3 34.2±26.3 41.4±29.9
Values are expressed as mean±standard deviation.
DM, diabetes mellitus; SBP, systolic blood pressure; DPP4, dipeptidyl 
peptidase 4; SGLT2, sodium-glucose cotransporter 2; BMI, body mass 
index; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cho-
lesterol; LDL-C, low-density lipoprotein cholesterol; HOMA-IR, ho-
meostatic model assessment for insulin resistance; HOMA-B, homeo-
static model assessment of β-cell function.
cholesterol level, low-density lipoprotein cholesterol level, tri-
glyceride level, and statin usage. The ORs of each model were 
expressed as values with 95% confidence intervals. All statisti-
cal analyses were performed using R software version 3.5.1 (R 
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Foundation for Statistical Computing, Vienna, Austria). P val-
ues <0.05 were considered to indicate statistical significance.
RESULTS
Baseline characteristics
The baseline characteristics of the participants are described in 
Table 1. The average age of the entire study sample was 58.6 
years for men and 60.7 years for women, while the average du-
ration of diabetes was 8.3 years for men and 8.5 years for wom-
en. The overall average circumferences of the thigh and waist 
were 44.5 cm (men, 45.2; women, 43.8) and 84.1 cm (men, 
87.1; women, 81.0), respectively. Table 2 shows the baseline 
clinical characteristics of male and female patients classified by 
Table 2. Baseline Clinical Characteristics According to Quartile of Thigh Circumference in Men and Women
Characteristic Q1 Q2 Q3 Q4
Men (n=1,569)
Thigh, cm 36–40 41–45 46–50 51–55
   Number of subjects   147 709 545 168
   Age, yr 63.1±10.0 59.2±10.1 54.5±10.0 47.9±9.8
   DM duration, yr 12.5±9.4 9.2±8.3 6.7±6.8 5.1±5.8
   Systolic blood pressure, mm Hg 129.0±18.4 130.6±17.0 131.5±14.9 131.6±14.7
   Hypertension (yes), % 26.5 36.2 33.4 32.7
   Use of antihyperglycemic agents, %
      Insulin 10.9 10.2 7.3 7.1
      Sulfonylurea 50.3 50.2 48.4 38.1
      Biguanide 55.1 55.6 48.4 38.1
      α-Glucosidase inhibitor 16.3 11.6 7.3 2.4
      Glitazone 3.4 8.9 8.6 7.1
      DPP4 inhibitor 13.6 13.3 10.8 10.1
      SGLT2 inhibitor 0 0.1 0.2 1.2
   Statin usage, % 17.7 19.3 19.3 18.5
   Exercise (yes), % 63.3 75.3 65.5 55.4
   Smoker (current), % 23.8 23.8 30.5 26.8
   Smoker (ex), % 44.2 48.7 47.5 44.6
   BMI, kg/m2 21.2±2.1 23.6±1.9 25.7±2.0 27.9±2.4
   Waist circumference, cm 80.1±6.7 85.1±6.4 89.6±6.2 93.2±6.9
   Hip circumference, cm 87.9±3.5 92.1±3.5 95.9±4.00 99.5±4.2
   Thigh circumference, cm 38.8±1.3 43.4±1.3 47.3±1.1 51.3±1.4
   Leg circumference, cm 32.8±1.9 35.1±1.9 37.1±2.1 39.5±2.2
   Waist-to-thigh ratio, cm/cm 1.82±0.13 1.90±0.13 1.96±0.13 2.04±0.14
   Fasting plasma glucose, mg/dL 169.5±70.8 159.6±49.9 158.6±47.8 163.6±55.3
   HbA1c, % 8.2±2.3 7.8±1.6 8.0±1.8 8.0±1.8
   Hemoglobin glycation index   −0.04±1.59 −0.13±1.19 0.03±1.24 −0.10±1.10
   C-peptide, ng/mL 1.82±0.92 1.98±0.91 2.13±0.78 2.49±1.01
   Total cholesterol, mg/dL 181.0±43.2 182.6±40.4 187.9±39.3 194.4±45.5
   Triglyceride, mg/dL 108.0±62.2 133.1±77.1 149.7±83.0 174.1±116.6
   HDL-C, mg/dL 49.7±11.6 47.6±11.4 45.9±9.8 44.5±10.4
   LDL-C, mg/dL 108.6±38.2 107.9±34.5 112.4±36.2 115.5±37.6
   HOMA-IR 2.5±1.5 2.7±1.6 2.9±1.8 3.6±2.4
   HOMA-B 29.0±24.5 32.5±24.9 35.7±26.0 41.1±31.9
(Continued to the next page)
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thigh circumference.
Characteristics of participants according to thigh 
circumference
In men, in addition to BMI and waist circumference, insulin re-
sistance, insulin secretion ability (as shown by C-peptide levels 
and HOMA-B) [26], and triglyceride levels increased as thigh 
circumference increased. A similar trend was evident in women 
(Table 2).
Table 2. Continued
Characteristic Q1 Q2 Q3 Q4
Women (n=1,506)
   Thigh, cm 34–39 40–43 44–47 48–53
   Number of subjects 154 571 568 213
   Age, yr 63.6±9.2 62.2±8.3 59.6±9.1 57.3±9.5
   DM duration, yr 11.1±8.6 9.8±8.3 7.4±7.1 5.9±6.5
   Systolic blood pressure, mm Hg 128.4±18.4 133.2±18.0 132.5±16.9 135.1±18.2
   Hypertension (yes), % 35.1 41.9 43.7 47.9
   Use of antihyperglycemic agents, %
      Insulin 11.7 14.2 12 8.9
      Sulfonylurea 53.2 54.3 49.3 44.1
      Biguanide 56.5 61.6 56.5 54
      α-Glucosidase inhibitor 13 11 8.6 8
      Glitazone 6.5 6.7 8.6 7.5
      DPP4 inhibitor 17.5 11.7 13.9 11.3
      SGLT2 inhibitor 0 0.2 0.2 0
   Statin usage, % 24.7 31.2 28.7 26.8
   Exercise (yes), % 66.2 69.7 65.3 57.3
   Smoker (current), % 3.2 1.9 1.9 1.4
   Smoker (ex), % 1.9 1.4 2.3 1.9
   BMI, kg/m2 21.0±3.1 22.9±2.4 24.9±2.3 27.5±2.6
   Waist circumference, cm 75.0±7.2 78.9±7.2 82.4±7.1 87.0±6.5
   Hip circumference, cm 86.3±3.4 89.1±3.9 92.8±4.4 97.2±4.9
   Thigh circumference, cm 37.9±1.2 41.7±1.1 45.3±1.1 49.4±1.5
   Leg circumference, cm 30.3±1.4 32.1±1.7 34.1±1.8 36.2±1.8
   Waist-to-thigh ratio, cm/cm 1.70±0.13 1.83±0.13 1.88±0.13 1.99±0.16
   Fasting plasma glucose, mg/dL 156.1±51.9 151.2±49.4 150.6±45.8 152.9±52.9
   HbA1c, % 8.1±2.0 7.8±1.6 7.8±1.7 7.8±1.6
   Hemoglobin glycation index 0.17±1.30 0.06±1.19 0.07±1.2 0.00±1.04
   C-peptide, ng/mL 1.83±1.17 1.88±0.86 2.14±1.06 2.30±0.88
   Total cholesterol, mg/dL 184.1±41.5 190.7±41.9 189.9±39.6 195.6±40.3
   Triglyceride, mg/dL 120.1±78.7 125.5±73.3 135.5±79.8 139.6±66.9
   HDL-C, mg/dL 52.7±14.7 52.6±13.0 51.4±12.1 50.3±12.1
   LDL-C, mg/dL 107.0±35.0 112.9±36.6 111.3±35.7 117.4±34.9
   HOMA-IR 2.6±1.7 2.9±2.0 3.1±2.1 3.6±2.6
   HOMA-B 34.8±27.1 39.5±28.7 42.5±29.8 48.1±33.9
Values are expressed as range or mean±standard deviation.
Q, quartile; DM, diabetes mellitus; DPP4, dipeptidyl peptidase 4; SGLT2, sodium-glucose cotransporter 2; BMI, body mass index; HbA1c, hemoglobin 
A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment for insulin 
resistance; HOMA-B, homeostatic model assessment of β-cell function.
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Relative risk of a positive HGI according to thigh and 
waist circumference
After adjustment, we observed that the larger the thigh circum-
ference, the smaller the risk of a positive HGI in men. In con-
trast, no difference in blood glucose variability was observed 
according to thigh circumference in women (Table 3). In men, 
Table 3. HGI According to Quartile of Thigh Circumference in Men and Women
Variable Q1 Q2 Q3 Q4
Men
   Number of subjects 147 709 545 168
   Positive HGI
      Unadjusted OR 1.000 0.825 (0.577–1.177) 0.903 (0.626–1.300) 0.711 (0.455–1.108)
      Adjusted OR (95% CI)a 1.000 0.751 (0.522–1.078) 0.747 (0.509–1.092) 0.523 (0.324–0.841)e
      Adjusted OR (95% CI)b 1.000 0.641 (0.437–0.937)d 0.548 (0.350–0.855)e 0.329 (0.182–0.591)f
      Adjusted OR (95% CI)c 1.000 0.670 (0.452–0.989)d 0.569 (0.360–0.896)d 0.349 (0.190–0.637)f
Women
   Number of subjects 154 571 568 213
   Positive HGI
      Unadjusted OR 1.000 1.039 (0.722–1.489) 0.979 (0.680–1.402) 0.991 (0.650–1.508)
      Adjusted OR (95% CI)a 1.000 1.060 (0.736–1.521) 1.036 (0.716–1.493) 1.083 (0.703–1.666)
      Adjusted OR (95% CI)b 1.000 0.970 (0.666–1.407) 0.860 (0.569–1.295) 0.797 (0.470–1.348)
      Adjusted OR (95% CI)c 1.000 0.954 (0.650–1.394) 0.866 (0.569–1.311) 0.826 (0.482–1.410)
HGI, hemoglobin glycation index; Q, quartile (Q1 was the lowest quartile); OR, odds ratio; CI, confidence interval.
aAdjusted for age and duration; bAs in a, and additionally adjusted for body mass index; cAs in b, and additionally adjusted for systolic blood pressure, ex-
ercise status, smoking status, hypoglycemic agent usage (insulin, sulfonylurea, biguanide, alpha-glucosidase inhibitor, glitazone, dipeptidyl peptidase-4 
inhibitor, or sodium-glucose transport protein-2 inhibitor), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and 
statin usage; dP<0.05 vs. Q1; eP<0.01 vs. Q1; fP<0.001 vs. Q1.
Table 4. HGI According to Quartiles of Waist Circumference in Men and Women
Variable Q1 Q2 Q3 Q4
Men, HGI range 68–81 82–86 87–91 92–107
   Number of subjects 343 414 389 423
   Positive HGI
      Unadjusted OR 1.000 0.974 (0.731–1.297) 1.256 (0.939–1.681) 1.163 (0.875–1.548)
      Adjusted OR (95% CI)a 1.000 0.968 (0.726–1.290) 1.246 (0.931–1.668) 1.141 (0.856–1.520)
      Adjusted OR (95% CI)b 1.000 1.014 (0.740–1.390) 1.349 (0.936–1.945) 1.296 (0.823–2.044)
      Adjusted OR (95% CI)c 1.000 0.966 (0.697–1.338) 1.264 (0.865–1.849) 1.203 (0.749–1.935)
Women, HGI range 60–75 76–80 81–85 86–103
   Number 361 382 338 425
   Positive HGI
      Unadjusted OR   1.000 1.133 (0.848–1.513) 1.277 (0.947–1.725) 1.547 (1.163–2.062)e
      Adjusted OR (95% CI)a 1.000 1.113 (0.832–1.488) 1.248 (0.923–1.687) 1.503 (1.127–2.006)e
      Adjusted OR (95% CI)b 1.000 1.162 (0.852–1.585) 1.345 (0.943–1.921) 1.709 (1.108–2.642)d
      Adjusted OR (95% CI)c 1.000 1.117 (0.811–1.539) 1.313 (0.908–1.901) 1.669 (1.062–2.630)d
HGI, hemoglobin glycation index; Q, quartile (Q1 was the lowest quartile); OR, odds ratio; CI, confidence interval.
aAdjusted for age and duration; bAs in a, and additionally adjusted for BMI; cAs in b, and additionally adjusted for systolic blood pressure, exercise status, 
smoking status, hypoglycemic agent usage (insulin, sulfonylurea, biguanide, alpha-glucosidase inhibitor, glitazone, dipeptidyl peptidase-4 inhibitor, or 
sodium-glucose transport protein-2 inhibitor), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and statin usage; 
dP<0.05 vs. Q1; eP<0.01 vs. Q1.
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no difference in the HGI according to waist circumference was 
observed. However, in women, the larger the waist circumfer-
ence, the higher the chance of a positive HGI even after adjust-
ment (Table 4).
We additionally divided patients into four groups by their 
waist-to-thigh circumference ratio to determine whether a rela-
Table 5. Association of the Presence of Carotid Artery Plaque with Quartiles of Thigh Circumference in Men and Women
Variable Q1 Q2 Q3 Q4
Men
   Number of subjects 147 710 547 171
   Plaque (+)
      Unadjusted OR 1.000 0.664 (0.441–0.983)d 0.460 (0.303–0.685)f 0.215 (0.131–0.345)f
      Adjusted OR (95% CI)a 1.000 0.916 (0.593–1.394) 0.899 (0.574–1.389) 0.634 (0.370–1.076)
      Adjusted OR (95% CI)b 1.000 0.708 (0.448–1.103) 0.548 (0.325–0.911)d 0.304 (0.156–0.586)f
      Adjusted OR (95% CI)c 1.000 0.755 (0.473–1.190) 0.587 (0.345–0.988)d 0.352 (0.178–0.689)e
Women
   Number of subjects 154 572 569 217
   Plaque (+)
      Unadjusted OR 1.000 0.801 (0.550–1.156) 0.631 (0.434–0.910)d 0.478 (0.311–0.730)f
      Adjusted OR (95% CI)a 1.000 0.884 (0.596–1.301) 0.860 (0.579–1.269) 0.767 (0.485–1.207)
      Adjusted OR (95% CI)b 1.000 0.818 (0.546–1.218) 0.730 (0.469–1.129) 0.587 (0.335–1.021)
      Adjusted OR (95% CI)c 1.000 0.734 (0.483–1.106) 0.714 (0.454–1.114) 0.590 (0.332–1.041)
Q, quartile (Q1 was the lowest quartile); OR, odds ratio; CI, confidence interval.
aAdjusted for age and duration; bAs in a, and additionally adjusted for body mass index; cAs in b, and additionally adjusted for systolic blood pressure, ex-
ercise status, smoking status, hypoglycemic agent usage (insulin, sulfonylurea, biguanide, alpha-glucosidase inhibitor, glitazone, dipeptidyl peptidase-4 
inhibitor, or sodium-glucose transport protein-2 inhibitor), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and 
statin usage; dP<0.05 vs. Q1; eP<0.01 vs. Q1; fP<0.001 vs. Q1.
Table 6. Association of the Presence of Carotid Artery Plaque with Quartiles of Waist Circumference in Men and Women
Variable Q1 Q2 Q3 Q4
Men
   Number of subjects 343 414 389 423
   Plaque (+)
      Unadjusted OR   1.000 0.950 (0.709–1.273) 0.949 (0.705–1.276) 1.067 (0.796–1.429)
      Adjusted OR (95% CI)a 1.000 0.981 (0.715–1.345) 0.998 (0.725–1.373) 1.207 (0.878–1.658)
      Adjusted OR (95% CI)b 1.000 0.877 (0.618–1.243) 0.826 (0.55–1.239) 0.894 (0.538–1.485)
      Adjusted OR (95% CI)c 1.000 0.824 (0.572–1.185) 0.734 (0.479–1.122) 0.831 (0.487–1.415)
Women
   Number of subjects 361 382 338 425
   Plaque (+)
      Unadjusted OR 1.000 1.321 (0.989–1.765) 1.234 (0.916–1.663) 1.459 (1.1–1.938)e
      Adjusted OR (95% CI)a 1.000 1.185 (0.874–1.607) 1.055 (0.77–1.444) 1.217 (0.903–1.64)
      Adjusted OR (95% CI)b 1.000 1.209 (0.873–1.673) 1.091 (0.752–1.582) 1.290 (0.821–2.027)
      Adjusted OR (95% CI)c 1.000 1.047 (0.745–1.469) 0.939 (0.635–1.387) 1.039 (0.645–1.675)
Q, quartile (Q1 was the lowest quartile); OR, odds ratio; CI, confidence interval.
aAdjusted for age and duration; bAs in a, and additionally adjusted for body mass index; cAs in b, and additionally adjusted for systolic blood pressure, ex-
ercise status, smoking status, hypoglycemic agent usage (insulin, sulfonylurea, biguanide, alpha-glucosidase inhibitor, glitazone, dipeptidyl peptidase-4 
inhibitor, or sodium-glucose transport protein-2 inhibitor), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and 
statin usage; dP<0.05 vs. Q1; eP<0.01 vs. Q1; fP<0.001 vs. Q1.
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tionship existed between HGI and the combination of thigh and 
waist circumference. After adjustment for potential confounding 
variables, the risk of a positive HGI was found to be higher 
when waist circumference was larger and thigh circumference 
was smaller (Fig. 1).
The risk of carotid plaque according to thigh circumference 
and waist circumference
In men, it was found that the larger the thigh circumference, the 
lower the risk of carotid plaque after adjustment for potential 
confounding variables. In women, a similar tendency was ob-
served before adjustment, but no statistically significant rela-
tionship was seen after adjustment (Table 5). In men, no differ-
ence in the presence of carotid plaque according to waist cir-
cumference was observed. In women, the presence of carotid 
plaque was higher in the thickest waist group compared to the 
reference group, but there is no statistical significance after ad-
justment (Table 6).
DISCUSSION
The clinical significance of blood glucose variability in the de-
velopment of diabetic complications has been recognized. 
Many parameters have been introduced to represent blood glu-
cose variability, such as the mean amplitude of glycemic excur-
sions [27], M-value [22], lability index [28], composite hypo-
glycemic score [28], average daily risk range [29], and others. 
In our study, we used the HGI as an indicator of blood variabili-
ty that can be easily used in clinical settings. The HGI has also 
been reported to be associated with diabetic complications [14].
The results of this study showed that men with type 2 diabetes 
were significantly less likely to exhibit a positive HGI as their 
thigh circumference increased. In contrast, no relationship was 
found between the risk of a positive HGI and thigh circumfer-
ence in women. As many muscles in our body are located in the 
thigh region, this result suggests that muscle mass impacts the 
HGI more strongly in men than in women.
In contrast, in women, the larger the waist circumference, the 
greater the risk of a positive HGI (a tendency not shown in 
men). In contrast to the aforementioned results based on thigh 
circumference, this indicates that the amount of fat has a greater 
effect on the HGI in women than in men.
As the waist-to-thigh circumference ratio increased, the likeli-
hood of a positive HGI also increased in both men and women. 
This indicates that both muscle mass and fat mass contribute to 
the presence of a positive HGI.
We observed clear correlations between thigh and waist cir-
cumference and the HGI in both men and women; however, in 
men, thigh circumference had a stronger correlation with the 
HGI than waist circumference, while the opposite was true in 
women. In other words, in the development of HGI in men, 
muscle appears to be more important than fat, while in women, 
fat appears to play a greater role than muscle. This may be be-
cause men have more muscle mass and less fat than women. To 
reduce the risk of complications caused by a high HGI, it is im-
portant to emphasize the importance of a high thigh circumfer-
ence in men and a low waist circumference in women.
In men, the smaller the thigh circumference, the higher the 
likelihood of carotid plaque. This tendency was not seen in 
women, which may be because men have a higher risk of arte-
riosclerosis than women.
In this study, the risk of a positive HGI increased as thigh cir-
cumference decreased in men and as waist circumference in-
creased in women. In addition, the larger the thigh circumfer-
ence, the lower the risk of carotid plaque in men.



















































Fig. 1. Odds ratio of positive hemoglobin glycation index (HGI) according to quartile (Q) of waist-to-thigh circumference ratio in (A) men 
and (B) women. aP<0.05 vs. Q1; bP<0.01 vs. Q1.
A B
Thigh Circumference, Hemoglobin Glycation Index, Glycemic Variability, and Carotid Plaque
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al studies such as the present study cannot determine the causal 
nature of relationships, as the temporality of relationships is dif-
ficult to establish [30]. Therefore, a prospective study is re-
quired for the accurate evaluation of thigh and waist circumfer-
ence and blood glucose variability. In addition, it is necessary to 
investigate the most suitable cut-off values of thigh circumfer-
ence, waist circumference, and waist-to-thigh circumference ra-
tio for the purposes of predicting the HGI and reducing compli-
cations.
The study examined only the relationship between thigh cir-
cumference and the presence of carotid plaque. However, if fur-
ther studies identify additional relationships between physical 
measurements and complications, indicators that can be more 
easily applied in clinical settings (e.g., BMI) may be discovered. 
As a final limitation, the subjects of this study were limited to 
patients at a single medical center in Seoul, so the results are 
unlikely to apply to all type 2 diabetes patients.
Nevertheless, many risk factors are combined in chronic dis-
eases such as diabetes, and as they have an unclear pathogenesis 
[30], more studies should be conducted to examine various fac-
tors in a similar fashion to this study. The present study is also 
meaningful because the primary indicators (namely thigh cir-
cumference and waist circumference) are familiar to patients 
and can be easily measured in clinical practice. 
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